Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Jim Cash who wrote (127)	7/25/1998 6:43:00 PM
From: Thomas Kirwin	Respond to of 422

Did You Know? Since 7/23/98: The three-month relative price strength rating of 87.00 for BLUD has been at least 20 percentage points above its 12-month relative strength. Research alerts for Immucor, Inc. On 7/22/98: Analysis of the most recent financial results for BLUD shows that the company's income per employee has been at least 10% above its industry average. Efficiency Since 2/6/98: Analysis showed that the price-to-cash-flow ratio of BLUD has been at least 25% above its industry average. As recently as 1/15/1998: Analysis shows that the price-to-sales ratio (PSR) of BLUD has been at least 25% below its industry's average. A PSR significantly below the industry average is one tool sometimes used to begin a search for undervalued stocks. Note: This information was gleaned from the MSN Investor Network. Regards, Tom